You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced ovarian cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Measure for Advanced Ovarian Cancer Patients Receiving Surgical

Not yet recruiting
  • Ovarian Cancer
  • +3 more
    • (no location specified)
    Mar 2, 2022

    Ovarian Cancer Trial (Fluzoparib, QL1101)

    Not yet recruiting
    • Ovarian Cancer
    • (no location specified)
    Oct 18, 2022

    Ovarian Cancer Trial in New York (90Y-hu3S193, 111In-hu3S193)

    Completed
    Has Results
    • Ovarian Cancer
    • 90Y-hu3S193
    • 111In-hu3S193
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    FIGO Stage III Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Carcinoma Trial in Amsterdam (Cisplatin 100 mg/m2, Cisplatin 40

    Not yet recruiting
    • FIGO Stage III Ovarian Cancer
    • +2 more
    • Cisplatin 100 mg/m2
    • Cisplatin 40 mg/l
    • Amsterdam, Netherlands
      Antoni van Leeuwenhoek (NKI-AVL)
    Jun 3, 2022

    New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

    Enrolling by invitation
    • Ovarian Cancer
    • +2 more
    • CRS scoring
    • Routine blood laboratory testing before treatment
    • Guangzhou, Guangdong, China
      The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    Nov 2, 2023

    Ovarian Cancer, Intraperitoneal Chemo Trial in Montpellier (Intraperitoneal chemo during surgery)

    Recruiting
    • Ovarian Cancer
    • Intraperitoneal Chemotherapy
    • Intraperitoneal chemotherapy during surgery
    • Montpellier, France
      Institut du Cancer de Montpellier - Val d'Aurelle
    Mar 11, 2022

    BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

    Active, not recruiting
    • BRCA1 Mutation
    • +4 more
    • Talazoparib Oral Capsule
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2022

    Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

    Not yet recruiting
    • Breast Cancer
    • +7 more
    • (no location specified)
    Sep 26, 2023

    Advanced Ovarian Cancer Trial in Spain (Olaparib, Pegylated Liposomal Doxorubicin)

    Completed
    • Advanced Ovarian Cancer
    • Sabadell, Barcelona, Spain
    • +7 more
    Jan 25, 2023

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Beijing (Fluzoparib; Apatinib, Fluzoparib, Placebo)

    Active, not recruiting
    • Ovarian Cancer
    • +2 more
    • Fluzoparib; Apatinib
    • +2 more
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Apr 22, 2022

    Advanced Ovarian Cancer Trial in Shanghai (Tranexamic Acid, normal saline)

    Completed
    • Advanced Ovarian Cancer
    • Tranexamic Acid
    • normal saline
    • Shanghai, Shanghai, China
      Shanghai Cancer Center, Fudan University
    May 30, 2022

    Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China

    Recruiting
    • Epithelial Ovarian Carcinoma Stage III
    • +5 more
    • nab-paclitaxel combined with carboplatin
    • Guangzhou, Guangdong, China
    • +10 more
    Feb 19, 2023

    Advanced Epithelial Ovarian Cancer Trial in Cairo (Carboplatin/paclitaxel)

    Completed
    • Advanced Epithelial Ovarian Cancer
    • Cairo, Egypt
      Pharmacology and toxicology department, Faculty of Pharmacy, Cai
    Jul 19, 2023

    Advanced Solid Tumor, Ovarian Cancer Trial in Richmond (Neratinib 160 mg, Neratinib 200 mg, Neratinib 240 mg)

    Recruiting
    • Advanced Solid Tumor
    • Ovarian Cancer
    • Neratinib 160 mg
    • +7 more
    • Richmond, Virginia
      Virginia Commonwealth University
    May 6, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Shanghai (Primary debulking surgery, Neoadjuvant

    Not yet recruiting
    • Ovarian Cancer
    • +2 more
    • Primary debulking surgery
    • +2 more
    • Shanghai, China
      Zhongshan Hospital, Fudan University
    Jan 17, 2022

    VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES

    Active, not recruiting
    • Ovarian Cancer
    • VIDEO-ASSISTED THORACOSCOPIC SURGERY
    • Alexandria, Egypt
      Alexandria University
    Apr 21, 2023

    Ovarian Cancer Trial in Jönköping, Kalmar, Linköping (Tranexamic acid, 0.9% NaCl solution)

    Completed
    Has Results
    • Ovarian Cancer
    • Tranexamic acid
    • 0.9% NaCl solution
    • Jönköping, Sweden
    • +2 more
    Jan 13, 2022

    Epithelial Ovarian Cancer, Ovarian Cancer, Ovarian Cancer Stage III Trial (Niraparib)

    Not yet recruiting
    • Epithelial Ovarian Cancer
    • +3 more
    • (no location specified)
    Jan 10, 2022

    Ovarian Cancer Trial in Seoul (Cellgram-DC)

    Terminated
    • Ovarian Cancer
    • Cellgram-DC
    • Seoul, Korea, Republic of
      Asan medical center
    Dec 29, 2022

    Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

    Recruiting
    • Advanced Ovarian Carcinoma
    • +7 more
    • Bydgoszcz, Kujawsko-pomorskie, Poland
    • +2 more
    Mar 7, 2023

    Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,

    Recruiting
    • Advanced Fallopian Tube Carcinoma
    • +21 more
    • Biopsy
    • +2 more
    • Bethesda, Maryland
    • +2 more
    Jan 25, 2023

    Advanced Solid Tumor, Platinum-resistant Ovarian Cancer Trial (SON-1010)

    Not yet recruiting
    • Advanced Solid Tumor
    • Platinum-resistant Ovarian Cancer
    • SON-1010
    • (no location specified)
    Mar 10, 2023

    Ovarian Cancer Trial in Hong Kong (Niraparib)

    Recruiting
    • Ovarian Cancer
    • Hong Kong, Hong Kong
      The University of Hong Kong
    Sep 27, 2021

    Ovarian Tumor Epithelial, Ovarian Cancer, Fallopian Tube Tumors Trial in India (Oregovomab, Paclitaxel, Carboplatin)

    Not yet recruiting
    • Ovarian Neoplasm Epithelial
    • +4 more
    • Oregovomab
    • +3 more
    • Visakhapatnam, Andhra Pradesh, India
    • +7 more
    Dec 7, 2022

    Ovarian Cancer Trial in Chengdu (Yangzheng Xiaoji, Niraparib)

    Not yet recruiting
    • Ovarian Cancer
    • Chengdu, Sichuan, China
      Sicchuan cancer hospital
    Nov 30, 2022